Coordinated action of protein tyrosine phosphatases in insulin signal transduction
- PMID: 11856336
- DOI: 10.1046/j.0014-2956.2002.02756.x
Coordinated action of protein tyrosine phosphatases in insulin signal transduction
Abstract
Insulin is the principal regulatory hormone involved in the tight regulation of fuel metabolism. In response to blood glucose levels, it is secreted by the beta cells of the pancreas and exerts its effects by binding to cell surface receptors that are present on virtually all cell types and tissues. In humans, perturbations in insulin function and/or secretion lead to diabetes mellitus, a severe disorder primarily characterized by an inability to maintain blood glucose homeostasis. Furthermore, it is estimated that 90-95% of diabetic patients exhibit resistance to insulin action. Thus an understanding of insulin signal transduction and insulin resistance at the molecular level is crucial to the understanding of the pathogenesis of this disease. The insulin receptor (IR) is a transmembrane tyrosine kinase that becomes activated upon ligand binding. Consequently, the receptor and its downstream substrates become tyrosine phosphorylated. This activates a series of intracellular signaling cascades which coordinately initiate the appropriate biological response. One important mechanism by which insulin signaling is regulated involves the protein tyrosine phosphatases (PTPs), which may either act on the IR itself and/or its substrates. Two well characterized examples include leuckocyte antigen related (LAR) and protein tyrosine phosphatase-1B (PTP-1B). The present review will discuss the current knowledge of these two and other potential PTPs involved in the insulin signaling pathway.
Similar articles
-
Tumor necrosis factor-alpha induces hepatic insulin resistance in obese Zucker (fa/fa) rats via interaction of leukocyte antigen-related tyrosine phosphatase with focal adhesion kinase.Diabetes. 2000 May;49(5):810-9. doi: 10.2337/diabetes.49.5.810. Diabetes. 2000. PMID: 10905491
-
Receptor-type protein tyrosine phosphatase epsilon (PTPepsilonM) is a negative regulator of insulin signaling in primary hepatocytes and liver.Zoolog Sci. 2005 Feb;22(2):169-75. doi: 10.2108/zsj.22.169. Zoolog Sci. 2005. PMID: 15738637
-
Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction.Mol Cell Biochem. 1998 May;182(1-2):101-8. Mol Cell Biochem. 1998. PMID: 9609119 Review.
-
Down-regulation of insulin signaling by protein-tyrosine phosphatase 1B is mediated by an N-terminal binding region.J Biol Chem. 2000 Aug 4;275(31):23642-7. doi: 10.1074/jbc.M001063200. J Biol Chem. 2000. PMID: 10807907
-
Regulation of insulin receptor signaling by protein-tyrosine dephosphorylation.Receptor. 1993 Spring;3(1):1-15. Receptor. 1993. PMID: 8394171 Review.
Cited by
-
An Isoform-Selective PTP1B Inhibitor Derived from Nitrogen-Atom Augmentation of Radicicol.Biochemistry. 2019 Jul 30;58(30):3225-3231. doi: 10.1021/acs.biochem.9b00499. Epub 2019 Jul 18. Biochemistry. 2019. PMID: 31298844 Free PMC article.
-
Protein tyrosine phosphatase 1B attenuates growth hormone-mediated JAK2-STAT signaling.Mol Cell Biol. 2003 Jun;23(11):3753-62. doi: 10.1128/MCB.23.11.3753-3762.2003. Mol Cell Biol. 2003. PMID: 12748279 Free PMC article.
-
Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma.Blood. 2022 Feb 3;139(5):717-731. doi: 10.1182/blood.2020008136. Blood. 2022. PMID: 34657149 Free PMC article.
-
Hepatic PTP1B Deficiency: The Promise of a Treatment for Metabolic Syndrome?J Clin Metab Diabetes. 2010 May;1(1):27-33. J Clin Metab Diabetes. 2010. PMID: 21533018 Free PMC article.
-
Regulation of mouse hepatic genes in response to diet induced obesity, insulin resistance and fasting induced weight reduction.Nutr Metab (Lond). 2005 Jun 28;2:15. doi: 10.1186/1743-7075-2-15. Nutr Metab (Lond). 2005. PMID: 15985155 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous